openPR Logo
Press release

Cancer Registry Software Market 2020-2026 Survey Report Along with Statistics || Leading Players - IBM Corporation; himagine solutions; Conduent, Inc.; McKesson Corporation; IACR Official Website;

03-05-2020 10:17 AM CET | IT, New Media & Software

Press release from: Data Bridge Market Research

Global Cancer Registry Software Market 2020

Global Cancer Registry Software Market 2020

This comprehensive Cancer Registry Software market report underlines the primary and secondary drivers, market share, possible sales volume, leading segments and geographical analysis. Other key market parameters range from industry outlook with respect to critical success factors (CSFs), industry dynamics that mainly covers drivers and restraints, market segmentation & value chain analysis, key opportunities, application and technology outlook, regional or geographical insight, country-level analysis, key company profiles, competitive landscape, to company market share analysis. This Cancer Registry Software Market business analysis report carries out an evaluation of the growth rate and the market value of Healthcare industry based on market dynamics and growth inducing factors.

Get Exclusive Sample Report + All Related Graphs & Charts Here@ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-cancer-registry-software-market

Global cancer registry software market is expected to rise to an estimated value of USD 107.41 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the presence of various mandates and regulations for the adoption of electronic health record systems.

Few of the major competitors currently working in the global cancer registry software market are Centers for Disease Control and Prevention; Elekta AB (pub); Onco, Inc.; C/NET Solutions; Ordinal Data, Inc.; IBM Corporation; himagine solutions; Conduent, Inc.; McKesson Corporation; IACR Official Website; NCRP; NeuralFrame, Inc.; F. Hoffmann-La Roche Ltd; among others.

Market Definition: Global Cancer Registry Software Market :-

Cancer registry software is defined as a management system designed for exhibiting greater management services in cancer registry. These software are capable of providing services required for better delivery of health care to patients such as collection, patient follow-up, abstraction of data, case finding and various other tools. This information is stored in a secured central data center to provide access to users at any point of time.

Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-cancer-registry-software-market

Segmentation: Global Cancer Registry Software Market :-

Cancer Registry Software Market : By Software

Cross-Disciplinary
Specific

Cancer Registry Software Market : By Type

Standalone
Integrated

Cancer Registry Software Market : By Deployment Model

On-Premise
Cloud-Based

Cancer Registry Software Market : By Database Type

Commercial
Public

Cancer Registry Software Market : By Functionality

Cancer Reporting to Meet State & Federal Regulations
Patient Care Management
Medical Research & Clinical Studies
Product Outcome Evaluation

Cancer Registry Software Market : By End-User

Government Organizations & Third-Party Administrators
Hospitals & Medical Practices
Private Payers
Pharmaceutical, Biotechnology & Medical Device Companies
Research Centers
Others

Cancer Registry Software Market : By Geography

North America
Europe
Asia-Pacific
South America
Middle East and Africa

Key Developments in the Cancer Registry Software Market:-

In April 2018, F. Hoffmann-La Roche Ltd announced that they had completed the acquisition of Flatiron Health. Flatiron Health is based out of New York City, United States and deals in provision of electronic health record software for oncology-specific applications which is subsequently utilized for development of evidence for cancer research. This acquisition is projected to enhance the levels of progress of both organizations as they aim to enhance the personalization of healthcare services for cancer patients

In October 2017, F. Hoffmann-La Roche Ltd announced the availability of "NAVIFY Tumor Board" solution designed for supporting the decision making process for patients suffering from cancer and reviewing their cases for tumor boards and multiple-disciplinary meetings. The solution will primarily be available for U.S., U.K., Germany, Spain, Sweden and Switzerland regions and can help the way these meetings are carried out.

Cancer Registry Software Market Drivers:-

Surging levels of patients suffering from cancer is expected to propel the growth of the market

Presence of various favorable initiatives by government organizations to reduce the incidences of cancer along with high adoption rate for this software from these organizations will boost the growth of the market

Increasing utilization of this software to survey the post-marketing impact of pharmaceuticals and therapeutics also acts as a market driver

Focus on improvement of health care facilities and quality along with reduction in the costs for provision of health care will augment the market growth in the forecast period

Cancer Registry Software Market Restraints:-

Chances of theft of confidential data amid high prevalence of cyber-attacks is expected to hinder the growth of the market
Lack of preference from a number of healthcare facilities to utilize advanced software solutions is expected to restrict this market growth

Competitive Analysis: Cancer Registry Software Market:-

Global cancer registry software market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cancer registry software market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Primary Respondents:-

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:-

Current and future of global cancer registry software market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:-

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Table of Content: Global Cancer Registry Software Market :-

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Cancer Registry Software Market Landscape

Part 04: Global Cancer Registry Software Market Sizing

Part 05: Global Cancer Registry Software Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Continue....

Table Of Contents Is Available Here@ https://www.databridgemarketresearch.com/toc?dbmr=global-cancer-registry-software-market&raksh

Contact Us

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Registry Software Market 2020-2026 Survey Report Along with Statistics || Leading Players - IBM Corporation; himagine solutions; Conduent, Inc.; McKesson Corporation; IACR Official Website; here

News-ID: 1955823 • Views:

More Releases from Data Bridge Market Research

Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 to 2029
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period. Market Overview This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031. Market Overview Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind
Radiology market registering a CAGR of 6.20% during the forecast period of 2022-2029
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Market Overview Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top